
Mindpeak builds AI-powered software that automates tissue diagnostics to speed and standardize cancer detection and biomarker quantification. It uses deep learning and medical-image analysis models deployed as clinical pathology software that integrates into existing laboratory workflows and diagnostics platforms. Products target pathology laboratories and clinical research institutions, automating repetitive tasks such as cell counting, biomarker scoring, and tumor classification. The company offers regulated diagnostic software (ISO 13485 certified) designed to improve reproducibility and support pathologists’ decision-making.

Mindpeak builds AI-powered software that automates tissue diagnostics to speed and standardize cancer detection and biomarker quantification. It uses deep learning and medical-image analysis models deployed as clinical pathology software that integrates into existing laboratory workflows and diagnostics platforms. Products target pathology laboratories and clinical research institutions, automating repetitive tasks such as cell counting, biomarker scoring, and tumor classification. The company offers regulated diagnostic software (ISO 13485 certified) designed to improve reproducibility and support pathologists’ decision-making.
What they do: AI-powered image analysis software for pathology to automate cancer detection and biomarker quantification
Founded: 2018
Headquarters / legal: Mindpeak GmbH, Hamburg
Recent funding: Series A announced Oct 2024 (~$15.3M)
Regulatory/certification: ISO 13485 certified (regulated diagnostic software)
| Company |
|---|
Digital pathology and histopathology image analysis for cancer diagnostics and biomarker quantification.
2018
Biotechnology
15.3M
Series A announced October 2024 (reported amount $15.3M)
3M
Seed round announced September 2019
“ZEISS Ventures; IFB Innovationsstarter; AI.FUND; Nina Capital; APEX Ventures; Motu Ventures; European Innovation Council”
Improving patient care at scale: Power efficient case routing in diagnostic labs so every case reaches the right expert faster. The setup: Execution-stage spin-off Location : Hamburg / Remote (travel required)
Initial investment from Mindpeak founders : €200k initial
Equity : 20% (part of a 40% founder pool)
Salary (early phase): ~€50–60k
Start : ASAP
The Opportunity We are spinning out a Case Distribution Tool from Mindpeak into an independent startup. This is a rare opportunity to build a core product in the pathology market from day one with real impact and real ownership.
The tool will help improve patient care by saving valuable time in diagnostic labs, enabling pathologists to focus on what matters most. The venture is backed by existing market validation, first customers, and close ties to Mindpeak. With true co-founder equity and full freedom to shape product and technology, this is a hands-on chance to turn a validated idea into a scalable, category-defining solution.
We are looking for a CTO co-founder to take ownership of the product and technology. What already exists:
The goal:
What You Bring Skills:
Founder Mindset (Important):